6-K

DIRECTOR DECLARATION

Company: Indivior Pharmaceuticals, Inc.
Filed: November 15, 2024
Period of Report: November 15, 2024
Accession Number: 0001654954-24-014512

View Document ↗ View on SEC.gov ↗